Yahoo Suche Web Suche

Anmelden

Suchergebnisse

  1. Suchergebnisse:

  1. de.wikipedia.org › wiki › John_FJohn F. Seymour – Wikipedia

    John F. Seymour (* 3. Dezember 1937 in Chicago, Illinois) ist ein US-amerikanischer Immobilieninvestor und Politiker ( Republikanische Partei ), der den Bundesstaat Kalifornien im US-Senat vertrat.

  2. scholar.google.com › citations‪John F Seymour‬ - ‪Google Scholar‬

    2022. Articles 1–20. ‪Professor of Medicine, Director Dept of Haematology Peter MacCallum Cancer Centre & Royal Melbourne‬ - ‪‪Cited by 65,964‬‬ - ‪Hematologic malignancies‬.

  3. Bilder

    • John F Seymour - Alchetron, The Free Social Encyclopedia
    • John Seymour (author) - Alchetron, The Free Social Encyclopedia
    • [Police Chief John F. Seymour] — Calisphere
    • John Seymour (1474-1536) – kleio.org
    • John Seymour - Babelio
    • The Hessian Sack: The Age of Healing by John Seymour
    • John Seymour, cable-laying Master Mariner.

    Alle anzeigen

  4. www.nejm.org › doi › fullVenetoclax–Rituximab in Relapsed or Refractory Chronic...

    21. März 2018 · Methods. In this randomized, open-label, phase 3 trial, we randomly assigned 389 patients to receive venetoclax for up to 2 years (from day 1 of cycle 1) plus rituximab for the first 6 months...

    • John F. Seymour, Thomas J. Kipps, Barbara Eichhorst, Peter Hillmen, James D’Rozario, Sarit Assouline...
    • 2018

  5. en.wikipedia.org › wiki › John_Seymour_(California_politician)John Seymour (California politician) - Wikipedia

    John Francis Seymour Jr. (born December 3, 1937) is an American retired politician who served as a United States senator from California from 1991 to 1992.

    • 6
    • 1955-1959
    • Judy Seymour
    • Republican

  6. Videos

    Alle anzeigen

  7. ashpublications.org › blood › articleDegraders upgraded: the rise of PROTACs in hematological...

    28. März 2024 · Casan and Seymour provide a state-of-the-art review of proteolysis-targeting chimeras (PROTACs), the leading class of targeted protein degradation agents.

  8. pubmed.ncbi.nlm.nih.gov › 34102145Should Undetectable Minimal Residual Disease Be the Goal of ... -...

    This review discusses available methods of minimal residual disease measurement. It summarizes minimal residual disease data from pivotal clinical trials and discusses potential implications for future studies and minimal residual disease-based clinical strategies.

  9. onlinelibrary.wiley.com › doi › 10Approach to relapsed CLL including Richter Transformation -...

    9. Juni 2023 · John F. Seymour. First published: 09 June 2023. https://doi.org/10.1002/hon.3146. Sections. PDF. Tools. This section will review the assessment and approved and generally available treatment options for patients with relapsed CLL, including the context of Richter Transformation (the development of diffuse large B-cell lymphoma). 1.